Metoprolol Zk Biofarm (Metoprolol Tartrate)

Metoprolol selectively blocks β1‑adrenergic receptors in the heart, preventing catecholamines such as adrenaline from stimulating these receptors. This inhibition reduces cyclic AMP formation, leading to slower heart‑node firing, decreased contractility, and lower cardiac output, which together lower blood pressure and heart rate.

The appropriate dose of Metoprolol Zk Biofarm is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and other factors such as renal function. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

The safety of Metoprolol Zk Biofarm in pregnancy and lactation has not been definitively established. Healthcare providers weigh potential benefits against possible risks before prescribing it to pregnant or nursing women. Patients should discuss their specific situation with a qualified professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metoprolol is a cardio‑selective (β1‑selective) blocker, which generally offers fewer respiratory side effects than non‑selective agents such as propranolol. Its pharmacokinetic profile allows once‑ or twice‑daily dosing, and it is widely used for hypertension and heart‑failure management, whereas some alternatives may be preferred for migraine prophylaxis or tremor control.

Metoprolol Zk Biofarm tablets should be stored at room temperature, below 25 °C. Keep them in the original packaging, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metoprolol Zk Biofarm is administered orally, typically as a whole tablet swallowed with water. The exact dosing schedule—once daily or divided doses—depends on the indication and the prescriber’s recommendation. Patients should not crush or chew the tablet unless specifically instructed.

Serious risks include severe bradycardia, heart block, marked hypotension, bronchospasm in patients with obstructive airway disease, and rare allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience fainting, severe shortness of breath, or signs of an allergic response.

Metoprolol Zk Biofarm is contraindicated in patients with known hypersensitivity to metoprolol or any component of the formulation, those with severe bradycardia, second‑ or third‑degree AV block without a pacemaker, and individuals experiencing cardiogenic shock. Caution is also advised for patients with uncontrolled asthma or severe peripheral vascular disease.